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ABSTRACT Yeast splicing factor Prp43, a DEAH box
protein of the putative RNA helicaseyRNA-dependent NTPase
family, is a splicing factor that functions late in the pre-mRNA
splicing pathway to facilitate spliceosome disassembly. In this
paper we report cDNA cloning and characterization of
mDEAH9, an apparent mammalian homologue of Prp43.
Amino acid sequence comparison revealed that the two pro-
teins are '65% identical over a 500-aa region spanning the
central helicase domain and the C-terminal region. Expres-
sion of mDEAH9 in S. cerevisiae bearing a temperature-
sensitive mutation in prp43 was sufficient to restore growth at
the nonpermissive temperature. This functional complemen-
tation was specific, as mouse mDEAH9 failed to complement
mutations in related splicing factor genes prp16 or prp22.
Finally, double label immunofluorescence experiments per-
formed with mammalian cells revealed colocalization of
mDEAH9 and splicing factor SC35 in punctate nuclear speck-
les. Thus, the hypothesis that mDEAH9 represents the mam-
malian homologue of yeast Prp43 is supported by its high
sequence homology, functional complementation, and colo-
calization with a known splicing factor in the nucleus. Our
results provide additional support for the hypothesis that the
spliceosomal machinery that mediates regulated, dynamic
changes in conformation of pre-mRNA and snRNP RNAs has
been highly conserved through evolution.
Pre-mRNA splicing in yeast and mammalian systems is a
multistep process involving recognition and assembly of pre-
mRNA splice sites into spliceosomal complexes, intron exci-
sion and exon ligation mediated by two transesterification
reactions, and release of splice products concomitant with
spliceosome disassembly (1–3). In contrast to self-splicing
group I introns, pre-mRNA splicing requires ATP and numer-
ous protein factors at multiple steps in the pathway. Among
these factors are a group of genetically defined Saccharomyces
cerevisiae genes (PRP2, -5, -16, -22, -28, -43) that are members
of a family of ‘‘DEADyDEAH box’’ proteins that contain
conserved motifs characteristic of RNA-dependent NTPases
and RNA helicases (4–6). More recently, an additional can-
didate pre-mRNA splicing factor (Slt22) with RNA-dependent
ATPase activity has been identified in association with the
U4yU6.U5 tri-snRNP in yeast (7, 8). The DEADyDEAH class
of splicing factor proteins may help catalyze the intricate series
of highly ordered small nuclear RNA (snRNA)–pre-mRNA
and snRNA–snRNA interactions required for successful splic-
ing. Alternatively, such proteins may serve a kinetic proof-
reading function to enhance fidelity of splicing (9).
Extensive genetic and biochemical analysis has allowed
temporal correlation of specific PRP gene functions with
specific steps in spliceosome assembly, catalysis, and spliceo-
some disassembly. PRP2 and Slt22 are required early in
assembly before the first catalytic step (8, 10–12); PRP16
activity is essential for the second catalytic step (13, 14); and
PRP22 functions during spliceosome disassembly (15). Results
in the accompanying paper (16) support the hypothesis that
PRP43 acts at a late stage of the disassembly process: alteration
of a conserved helicase motif in mutant prp43 allele yielded a
phenotype characterized by excess accumulation of spliceoso-
mal complexes retaining excised intron lariats. However, many
mechanistic details of the reactions catalyzed by this intriguing
class of enzymes, including the precise RNA substrate and the
secondary structural change presumably effected by each,
remain to be fully elucidated.
Thus far, few counterparts of these yeast DEADyDEAH box
splicing factors have been identified in Drosophila or mam-
malian systems. Evidence that such factors are expressed in
mammalian cells was provided by the recent identification and
characterization of HRH1, a mammalian homologue of yeast
Prp22. Wild-type HRH1 protein exhibits extensive sequence
homology with Prp22, functionally complements prp22 muta-
tions in yeast, and is localized to nuclear splicing domains in
cultured cells (17, 18). Moreover, dominant-negative mutants
of HRH1 inhibit pre-mRNA splicing in vivo and inhibit release
of spliced products from spliceosomal complexes in vitro (18).
These results strongly support the hypothesis that HRH1 and
Prp22 are functional homologues.
In this paper we identify a mammalian homologue of a
second yeast DEAH box splicing factor, Prp43. The mouse
homologue, designated mDEAH9, was cloned initially by
reverse transcriptase (RT)yPCR using degenerate oligonucle-
otides to conserved helicase motifs. By the criteria of amino
acid sequence homology to Prp43, functional complementa-
tion of prp43 mutants, and immunofluorescence localization of
mDEAH9 in the nucleus, mDEAH9 appears to represent a
mammalian homologue of yeast splicing factor Prp43.
MATERIALS AND METHODS
Strategy for Cloning mDEAH9. Degenerate oligonucleotide
primers were designed to hybridize with two conserved se-
quences encoding the ‘‘GKT’’ and ‘‘DEAH’’ amino acid motifs.
The primers used were as follows. Sense strand primer 1,
59-CGGAATTCACIGGITCIGGIAA(GyA)AC-39; antisense
strand primer 2, 59-CGGAATTC(TyC)(TyC)(TyGyC)(Ay
G)T(CyG)IGC(TyC)TC(AyG)-39. Underlined bases repre-
sent EcoRI sites added to facilitate subcloning. Mouse eryth-
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roleukemia (MEL) cell RNA was amplified by RTyPCR,
yielding a mixture of products of '300–310 nucleotides. A
subcloned fragment with high homology to PRP43 was used as
a probe for isolation of multiple overlapping cDNAs from two
different MEL cell cDNA libraries. One library, constructed in
the plasmid vector pXM, was a gift of Alan D’Andrea (Dana–
Farber Cancer Institute, Harvard Medical School, Boston).
The other was purchased from CLONTECH (Palo Alto, CA)
and was constructed in lgt10. Both libraries yielded clones
with identical sequence in extensive regions of overlap.
Complementation of Temperature-Sensitive prp43. Yeast
expression vector pRS426pG1 (a gift of T.-H. Chang, Ohio
State University) was modified by insertion of an EcoRI site
at the BamHI cloning site, and mDEAH9 cDNA was inserted
into the EcoRI site. Plasmid DNAs were introduced into S.
cerevisiae by the LiCl technique and transformants were se-
lected by growth on uracil2 agar plates at the permissive
temperature of '23°C.
Immunofluorescence. WI38 cells, diploid human fetal lung
fibroblasts, were grown in Dulbecco’s modified Eagle’s me-
dium (DMEM; GIBCO) containing 10% fetal bovine serum,
4 mM glutamine, and antibiotics (50 unitsyml penicillin and 50
mgyml streptomycin). Cells grown on coverslips for 1–2 days
were rinsed twice in phosphate-buffered saline (PBS) at pH
FIG. 1. (A) Domain structure of mouse mDEAH9 and yeast Prp43 proteins. Numbers represent percent identity of amino acid sequence in
each domain. Highest homology ('72% identity) is observed in the central domain, which contains motifs shared with the DEAD box family of
putative RNA helicases. Homology is much weaker (,30%) in the N-terminal region. Arrows indicate position of primers used to amplify a region
of mDEAH9 in the early cloning experiments. (B) Amino acid sequence comparison of mDEAH9, Prp43, and a related Caenorhabditis elegans
protein. The N-terminal residues 1–30 of mDEAH9 were deduced by sequence analysis of a mouse embryo expressed sequence tag (EST) clone
(GenBank accession no. W84193) and the remainder from MEL cDNAs. The source of other sequences is as follows: human HRH2, ref. 17; C.
elegans, accession no. U13644.
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7.4, fixed for 10 min at 4°C in PBS containing 2% formalde-
hydey0.2% Triton X-100, further permeabilized with 1%
Triton X-100 for 10 min at room temperature, immersed in
cold acetone for 5 min, and rinsed twice in PBS. All subsequent
incubations were for 1 hr at room temperature in PBS con-
taining 10 mgyml bovine serum albumin and additions as
indicated. After incubation in 10% goat serum to block
nonspecific protein binding, fixed cells were incubated with the
two primary antibodies: affinity-purified rabbit IgG against
mDEAH9, and mouse monoclonal antibody to SC-35 (19)
(hybridoma cell supernatant, a gift of X.-D. Fu, Univ. of
California, San Diego). After washing, the cells were incubated
with fluorescein isothiocyanate (FITC)-conjugated goat anti-
rabbit IgG (Molecular Probes) and tetramethylrhodamine-
conjugated goat anti-mouse IgG (Sigma). Cells were stained
with 49,6-diamidino-2-phenylindole (DAPI) to confirm nu-
clear localization of immunofluorescent signals and washed,
and the coverslips were mounted on slides by using Vectashield
(Vector Laboratories). Alternate fixation methods (omitting
the final acetone step or substituting ethanol for acetone) gave
essentially the same results, although the nuclear signals were
somewhat more diffuse.
Confocal Microscopy. A Bio-Rad confocal laser scanning
microscope (MRC 1000) equipped with a Nikon Diaphot 200
with a f luor 603 1.4 numerical aperature Planapo oil-
immersion lens was used to obtain optical sections of WI38
cells. An argon laser (l 5 488 nm) was used to excite
fluorescein and a heliumyneon laser (l 5 543 nm), to excite
rhodamine. Images spanning the entire nucleus were con-
structed by means of Bio-Rad software. The limit of resolution
in this system was 0.2 mm.
RESULTS
To clone candidate splicing factor cDNAs of the DEADyH box
family of putative RNA helicases, we amplified MEL cell RNA
with oligonucleotide primers corresponding to two conserved
helicase motifs (GKT and DEAH) (Fig. 1A). A diffuse band of
'300–310 nt was obtained, which upon subcloning and se-
quencing was found to include fragments of at least three
distinct cDNAs with homology to the DEAH box family. One
of these (mDEAH6) exhibited high homology to the yeast
splicing factor PRP22 (15) and near identity with its human
homologue HRH1 (data not shown). A second cDNA frag-
ment, mDEAH9, was highly homologous to the newly de-
scribed yeast splicing factor PRP43 (16) and the partial cDNA
encoding human HRH2 (17). The mDEAH9 cDNA was
utilized as a probe for screening traditional cDNA libraries
(from MEL cells), as well as GenBank expressed sequence tag
(EST) libraries, allowing assembly of an '2.7-kb cDNA pre-
dicted to encode a protein of 758 amino acids (Fig. 1B).
The deduced amino acid sequence of mDEAH9 revealed a
protein with the typical tripartite structure found in other
members of the DEAH splicing factor proteins: a unique
N-terminal domain, a central helicase domain containing
conserved motifs shared by both DEAD and DEAH-type
members of the RNA helicase family, and a C-terminal domain
characteristic of the DEAH subclass. Homology between
mouse mDEAH9 and S. cerevisiae Prp43 is very high in the
helicase domain (72% identity) and in the C-terminal domain
(64% identity), but much lower in the N-terminal region. For
comparison, mDEAH9 and HRH2 are 98% identical in the
helicase domain. Interestingly, the primary sequence of the
N-terminal domain exhibits two repeating sequences of un-
known importance: a stretch of predominantly charged amino
acids with alternating acidic and basic residues, and another
region with seven repeats of the tripeptide (AyT)-H-S (Fig.
1B).
Pairwise comparison of the full-length mDEAH9 sequence
to other known DEAH proteins supports the hypothesis that
it represents the mammalian homologue of Prp43. Over the
'500-aa region spanning the helicase and C-terminal domains,
mDEAH9 is more closely related to Prp43 than it is to other
putative helicases from mammalian sources (HRH1, RNA
helicase A), to the Drosophila mle protein, or to yeast splicing
factors Prp2, Prp16, and Prp22. Indeed, mDEAH9 was found
to be more closely homologous to Prp43 than to any other
predicted open reading frame in the recently completed S.
cerevisiae sequence (data not shown). Conversely, Prp43 is
more similar to mouse mDEAH9 than it is to other yeast
members of this family, including Prp2, Prp16, and Prp22.
Homology searches of the GenBank databases for genes
similar to PRP43ymDEAH9 revealed close homologues in
plants (Arabidopsis, not shown) and nematodes (C. elegans).
Alignment of these sequences demonstrated a consistently
high degree of sequence identity from the GKT nucleotide
binding motif almost to the C terminus, a span of '500 aa (Fig.
1B). In contrast, the length and primary sequence of the
N-terminal domains is more variable between species. Of note,
however, this domain in all of the higher eukaryotic homo-
logues is rich in charged residues, with multiple simple repeats
of basic and acidic residues, suggesting that these conserved
elements may be functionally important.
To explore whether the extensive structural homology be-
tween mouse mDEAH9 and yeast Prp43 proteins is indicative
of a conserved physiological function, we tested whether
mDEAH9 expression in vivo could functionally complement
prp43 mutations. For this study we employed a yeast strain
bearing a temperature-sensitive mutation (Gly-3953 Asp) in
the helicase domain of Prp43, which can grow normally at 23°C
but not 35°C (16). Mutant yeast cells transformed with the
yeast expression vector pRS426pG1 containing mDEAH9
cDNA were tested for growth at the nonpermissive tempera-
ture. As shown in Fig. 2, mDEAH9 cDNA rescued the growth
defect at 35°C, allowing growth of single colonies within 4–6
days. Cells transformed in parallel with the expression vector
alone did not yield single colonies at 35°C even after 14 days.
Control experiments revealed that this functional complemen-
tation was specific—i.e., mDEAH9 did not rescue growth of
temperature-sensitive alleles of prp22 or prp16 (not shown).
Positive control plasmid p316JA1, encoding the wild-type
Prp43 protein, promoted growth at 35°C after only 2–3 days.
Thus, mDEAH9 complements the prp43 mutation specifically,
but less efficiently than the native yeast protein.
The ability of mouse mDEAH9 to rescue the growth defect
in prp43 temperature-sensitive mutant yeast suggests that
mDEAH9 is a functional homologue of PRP43. If indeed
FIG. 2. Functional complementation of prp43 mutant by mDEAH9
cDNA. S. cerevisiae transformed with the indicated plasmids was
streaked out on uracil2 agar plates and incubated at nonpermissive
(35°C) temperatures for 7 days. Expression of mDEAH9, but not the
vector alone, rescued growth at nonpermissive temperatures.
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mDEAH9 functions in the mammalian pre-mRNA splicing
pathway, this hypothesis predicts that mDEAH9 should be a
nuclear protein, and it might colocalize with known splicing
factors in the nucleus. To examine the subcellular localization
of mDEAH9, we performed a series of immunofluorescence
experiments, using (i) affinity-purified rabbit polyclonal anti-
bodies directed against a synthetic peptide in the unique N
terminus of mDEAH9, and (ii) a well characterized mouse
monoclonal antibody against splicing factor SC35 (19). The
human fibroblast cell line WI38 stained with anti-mDEAH9
plus FITC-conjugated anti-rabbit IgG (Fig. 3A) and anti-SC35
plus rhodamine-conjugated anti-mouse IgG (Fig. 3B), yielded
punctate ‘‘speckled’’ patterns of nuclear fluorescence. Most
importantly, these patterns were largely coincident, as indi-
cated by the yellow generated when the two patterns were
superimposed (Fig. 3C). 49,6-Diamidino-2-phenylindole stain-
ing confirmed that the speckled patterns were indeed nuclear;
little or no cytoplasmic staining was observed (not shown).
These immunof luorescence studies demonstrate that
mDEAH9 and SC35 colocalize in nuclear speckles believed to
represent storage sites for pre-mRNA splicing factors (20),
consistent with a role for mDEAH9 in pre-mRNA splicing.
To characterize the expression of mDEAH9 in various mouse
tissues, Northern blot analysis was performed (Fig. 4). All tissues
tested, including heart, brain, spleen, lung, liver, skeletal muscle,
kidney, testis, and MEL cells (not shown) expressed an mRNA of
'3.4 kb (Fig. 4 Upper). Differences in signal intensity were largely
attributable to variations in RNA loading, as indicated by the
intensity of hybridization with an actin cDNA probe (Fig. 4
Lower). This apparently ubiquitous expression of mDEAH9 is
consistent with a role as an essential splicing factor.
Finally, phylogenetic conservation of mDEAH9 gene se-
quences was examined by Southern blot hybridization to genomic
FIG. 3. Compartmentalization of mDEAH9 in nuclear speckles. Images show a human WI38 fibroblast processed for double-label
immunofluorescence with antibodies against both mDEAH9 and SC35. (31,200.) (A) mDEAH9 staining visualized with an FITC-conjugated
anti-rabbit IgG (green). (B) Anti-SC35 staining of the same cells visualized with rhodamine-conjugated anti-mouse IgG (red). (C) Superimposition
of the anti-mDEAH9 plus anti-SC35 immunofluorescence signals, showing colocalization of the two antigens (yellow). Individual focal planes
containing both fluorochromes also show overlap, although the areas stained by SC-35 (red) are slightly larger than the mDEAH9-stained speckles.
FIG. 4. Expression of mDEAH9 mRNA in mouse tissues. A
multiple tissue Northern blot (CLONTECH), containing 2 mg of total
RNA from the indicated mouse tissues, was hybridized with a 32P-
labeled mDEAH9 cDNA probe (Upper) or an actin cDNA probe
(Lower) under stringent conditions. Lanes: 1, heart; 2, brain; 3, spleen;
4, lung; 5, liver; 6, skeletal muscle; 7, kidney; and 8, testis.
FIG. 5. Conservation of mDEAH9 gene sequences among verte-
brate species. A Zoo-Blot (CLONTECH) containing 8 mg of EcoRI-
digested genomic DNA was hybridized with 32P-labeled mDEAH9
cDNA probe under stringent conditions. Lanes: 1, human; 2, monkey;
3, rat; 4, mouse; 5, dog; 6, cow; 7, rabbit; 8, chicken; and 9, S. cerevisiae.
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DNA from several species on a Zoo-Blot (Fig. 5). Strong cross-
hybridization of mouse mDEAH9 cDNA was observed to DNA
from human, monkey, rat, dog, cow, rabbit, and chicken origin.
However, despite the considerable amino acid sequence homol-
ogy between mDEAH9 and Prp43 proteins, little or no cross-
hybridization was seen between mDEAH9 cDNA and S. cerevi-
siae genomic DNA (Fig. 5, lane 9). This is due to considerable
sequence divergence at the wobble base of many codons, which
lowers the overall DNA sequence homology. As a control for
specificity, the Zoo-Blot was reprobed with a partial cDNA
representing the mouse homologue of HRH1, designated
mDEAH6. A distinct pattern of hybridizing genomic fragments
was observed, confirming that individual DEAH hybridization
probes do not cross-react with related family members under the
conditions employed (results not shown).
DISCUSSION
In this paper we characterize a mouse cDNA, designated
mDEAH9, that encodes a novel member of the DEAH box family
of putative RNA helicases and RNA-dependent NTPases. Sev-
eral lines of evidence support the hypothesis that mDEAH9
represents a mammalian homologue of the yeast splicing factor
Prp43 (16). First, the degree of phylogenetic sequence conser-
vation is remarkable. The mouse mDEAH9 and S. cerevisiae
Prp43 proteins are .65% identical over 500 amino acids, a level
of homology comparable to that seen between yeast (Tif) and
mouse (eIF-4A) translation initiation factors. Another manifes-
tation of its evolutionary conservation, at the nucleotide level, is
the specific cross-hybridization of mDEAH9 cDNA with genomic
DNA from various species (Fig. 5). Second, mDEAH9 was able
to complement a temperature-sensitive prp43 mutant so as to
facilitate growth at otherwise nonpermissive temperatures, dem-
onstrating conservation of function between mDEAH9 and
Prp43. Third, immunofluorescence experiments show that
mDEAH9 colocalizes with splicing factor SC35 in nuclear speck-
les, the presumptive storage site for pre-mRNA splicing factors
(21). The latter experiment demonstrates that mDEAH9 is
localized exactly as might be predicted for a candidate splicing
factor. Finally, mDEAH9 appears by Northern blot analysis to be
widely expressed among mouse tissues, as would be expected for
a constitutive component of the cellular splicing machinery.
The homology of mDEAH9 to DEADyH box proteins in
general, and to Prp43 in particular (16), provides clues as to its
possible biochemical function in pre-mRNA splicing. mDEAH9,
like the related splicing factors Prp2, Prp16, and Prp22, is likely to
possess RNA-dependent NTPase activity and may account in part
for the ATP requirement during pre-mRNA splicing (9). More-
over, since some DEADyH box proteins have ATP-dependent
RNA unwinding activity, mDEAH9 is a candidate RNA helicase
as well. Experiments with a prp43 temperature-sensitive mutant
are consistent with a role late in the splicing process, during
spliceosome disassembly (16); mDEAH9 may thus function after
the biochemical steps of splicing to promote release of splicing
products and recycling of components for another round of
splicing. It is interesting to speculate that mDEAH9 may bind to
one or more of the splicing product RNAs and utilize an RNA-
dependent NTPase activity to promote a critical conformational
change in either the RNA itself (e.g., by helicase action) or in an
interacting spliceosomal protein; either of these may be required
for disassembly and recycling of spliceosomal components.
One intriguing question about RNA processing concerns the
extent to which the nuclear splicing machinery in higher
eukaryotes resembles that in yeast, despite the vastly different
magnitude and complexity of the splicing problem in the two
types of organism. How similar might the splicing machinery
be in S. cerevisiae—where most genes are intronless or contain
a single intron with well conserved splice sites—versus higher
eukaryotes—where most genes possess multiple introns with
less well defined splice sites and often complicated alternative
splicing patterns? It has been well established that the major
snRNA components of the small nuclear ribonucleoprotein
(snRNP) particles exhibit considerable conservation of sec-
ondary structure and function (e.g., see ref. 22). More recently,
a number of core snRNP proteins with identifiable homo-
logues in both yeast and higher eukaryotic systems have been
reported, including components of the U1 snRNP (23, 24); the
U2 snRNP (25–28); and the U5 snRNP (29, 30). Relatively
little is known about conservation of non-snRNP splicing
factors, but here too progress is being made. The recently
described human HRH1 protein, a DEADyH box protein and
apparent homologue of S. cerevisiae Prp22, is one example. The
structural and functional similarity between mDEAH9 and
Prp43 represents a second example of evolutionary conserva-
tion of non-snRNP splicing factors. Such findings suggest that
yeast and mammalian splicing machineries probably utilize
similar strategies and protein components to orchestrate the
dynamic base pairing interactions that occur during pre-
mRNA splicing (31). Future biochemical experiments, testing
the effects of quantitative and qualitative variations in
mDEAH9 protein on the efficiency of pre-mRNA splicing, will
be required to define more precisely the role of mDEAH9.
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